Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: Evidence for gender differences in the studies of left ventricular dysfunction trials

Journal of the American College of Cardiology

Volumn 29, Issue 5, 1997, Pages 1074-1080

  Dries, Daniel L ^a,b   Rosenberg, Yves D ^a   Waclawiw, Myron A ^a   Domanski, Michael J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SINUS RHYTHM; THROMBOEMBOLISM;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STROKE VOLUME; SYSTOLE; THROMBOEMBOLISM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030894209     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00019-3     Document Type: Article

References (20)

1. Massumi RA, Rios JC, Gooch AS, Nutter D, De Vita VT, Datlow DW. Primary myocardial disease report of fifty cases and review of the subject . Circulation. 31:1965;19-41.
2. Fuster V, Gersh B, Giuliani E, Tajik A, Brandenberg R, Frye R. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 47:1981;525-530.
3. Segal J, Stapleton J, McClellan J, Waller BF, Harvey WP. Idiopathic cardiomyopathy clinical features, prognosis, and therapy . Curr Probl Cardiol. 3:1978;1-49.
4. Hatle L, Orjavik O, Storstein O. Chronic myocardial disease I: Clinical picture related to long-term prognosis . Acta Med Scand. 199:1976;399-405.
5. Gottdiener JS, Gay JA, Van Voorhees L, Di-Bianco R, Fletcher RD. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy assessment by 2-dimensional echocardiography . Am J Cardiol. 52:1983;1281-1285.
6. Kyrle P, Koringer C, Gossinger H, et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost. 54:1985;521-523.
7. Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrel L, Cohn JN. Incidence of thromboembolic events in congestive heart failure. Circulation. 87:1983;94-101.
8. Katz SD, Marantz PR, Biasucci L, et al. Low incidence of stroke in ambulatory patients with heart failure a prospective study . Am Heart J. 126:1993;141-146.
9. Baker DW, Wright RF. Management of heart failure IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction . JAMA. 272:1994;1614-1618.
10. Meltzer RS, Visser CA, Fuster V. Intracardiac thrombi and systemic embolization. Ann Intern Med. 104:1986;689-698.
11. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 1995;92:2764-84.
12. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
13. Predictors of thromboembolism in atrial fibrillation I: Clinical features of patients at risk . Ann Intern Med. 116:1992;1-5.
14. Studies of Left Ventricular Dysfunction (SOLVD) - rationale, design and methods two trials that evaluate the effect of enalapril in patients with reduced ejection fraction . Am J Cardiol. 66:1990;315-322.
15. Kyrle P, Korninger C, Gossinger H, et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost. 54:1985;521-523.
16. Segal J, Stapleton J, McClellan J, Waller BF, Harvey WP. Idiopathic cardiomyopathy clinical features, prognosis, and therapy . Curr Probl Cardiol. 3:1978;1-49.
17. Yokata Y, Kawanishi H, Hayakawa M, et al. Cardiac thrombus in dilated cardiomyopathy relationship between left ventricular pathophysiology and left ventricular thrombus . Jpn Heart J. 30:1989;1-11.
18. Gitter MJ, Jaeger TM, Petterson TM, Gersh BJ, Silverstein MD. Bleeding and thromboembolism during anticoagulant therapy a population-based study in Rochester, Minnesota . Mayo Clin Proc. 70:1995;725-733.
19. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation a major contributor to stroke in the elderly: the Framingham Study . Arch Intern Med. 147:1987;1561-1564.
20. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke the Framingham Study . Stroke. 22:1991;983-988.